Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: Activation of the epiregulin gene

Cancer Research

Volumn 63, Issue 8, 2003, Pages 1743-1747

  Lindvall, Charlotta ^a   Hou, Mi ^a   Komurasaki, Toshi ^c   Zheng, Chengyun ^a,d   Henriksson, Marie ^b   Sedivy, John M ^e   Björkholm, Magnus ^a   Teh, Bin Tean ^f   Nordenskjöld, Magnus ^a   Xu, Dawei ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c TAISHO PHARMACEUTICAL CO LTD   (Japan)

^d SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

^e BROWN UNIVERSITY   (United States)

^f VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; EPIREGULIN; GROWTH FACTOR; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

CELL GROWTH; CELL IMMORTALIZATION; CELL TRANSFORMATION; COLONY FORMATION; COMPARATIVE STUDY; CONFERENCE PAPER; DNA MICROARRAY; EXPRESSED SEQUENCE TAG; FIBROBLAST; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENETIC CODE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL;

CELL AGING; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; TELOMERASE; UP-REGULATION;

EID: 0344837729     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Wright, W. E., and Shay, J. W. Historical claims and current interpretations of replicative aging. Nat. Biotechnol., 20: 682-688, 2002.
2. Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C. P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., and Wright. W. E. Extension of life-span by introduction of telomerase into normal human cells. Science (Wash. DC), 279: 349-352, 1998.
3. Liu, J. P. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J., 13: 2091-2104, 1999.
4. Jiang, X. R., Jimenez, G., Chang, E., Frolkis, M., Kusler, B., Sage, M., Beeche, M., Bodnar, A. G., Wahl, G. M., Tlsty, T. D., and Chiu, C. P. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat. Genet., 21: 111-114, 1999.
5. Morales, C. P., Holt, S. E., Ouellette, M., Kaur, K. J., Yan, Y., Wilson, K. S., White, M. A., Wright, W. E., and Shay, J. W. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat. Genet., 21: 115-118, 1999.
6. Stewart, S. A., Hahn, W. C., O'Connor, B. F., Banner, E. N., Lundberg, A. S., Modha, P., Mizuno, H., Brooks, M. W., Fleming, M., Zimonjic, D. B., Popescu, N. C., and Weinberg, R. A. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc. Natl. Acad. Sci. USA, 99: 12606-12611, 2002.
7. Wang, J., Hannon, G. J., and Beach, D. H. Risky immortalization by telomerase. Nature (Lond.), 405: 755-756, 2000.
8. Toyoda, H., Komurasaki, T., Uchida, D., and Morimoto, S. Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family. Biochem. J., 326 (Pt. 1): 69-75, 1997.
9. Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., and Weinberg, R. A. Creation of human tumour cells with defined genetic elements. Nature (Lond.), 400: 464-468, 1999.
10. Wei, S., and Sedivy, J. M. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. Cancer Res., 59: 1539-1543, 1999.
11. Komurasaki, T., Toyoda, H., Uchida, D., and Morimoto, S. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor. ErbB-2, ErbB-3, and ErbB-4. Oncogene, 15: 2841-2848, 1997.
12. Shirakata, Y., Komurasaki, T., Toyoda, H., Hanakawa, Y., Yamasaki, K., Tokumaru, S., Sayama, K., and Hashimoto, K. Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J. Biol. Chem., 275: 5748-5753, 2000.
13. Takahashi, M., Rhodes, D. R., Furge, K. A., Kanayama, H., Kagawa, S., Haab, B. B., and Teh, B. T. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc. Natl. Acad. Sci. USA, 98: 9754-9759. 2001.
14. Xu, D., Gruber, A., Bjorkholm, M., Peterson, C., and Pisa, P. Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms. Br. J. Cancer, 80: 1156-1161, 1999.
15. Xu, D., Wang, Q., Gruber, A., Bjorkholm, M., Chen, Z., Zaid, A., Selivanova, G., Peterson, C., Wiman, K. G., and Pisa, P. Down-regulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene, 19: 5123-5133, 2000.
16. Toyoda, H., Komurasaki, T., Uchida, D., Takayama, Y., Isobe, T., Okuyama, T., and Hanada, K. Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J. Biol. Chem., 270: 7495-7500, 1995.
17. Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., Pereira-Smith, O., et al. A biomarker that identifies seriescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA, 92: 9363-9367, 1995.
18. Thogersen, V. B., Sorensen, B. S., Poulsen, S. S., Omtoft, T. F., Wolf, H., and Nexo, E. A subclass of HER 1 ligands are prognostic markers for survival in bladder cancer patients. Cancer Res., 61: 6227-6233, 2001.
19. Baba, I., Shirasawa, S., Iwamoto, R., Okumura, K., Tsunoda, T., Nishioka, M., Fukuyama, K., Yamamoto, K., Mekada, E., and Sasazuki, T. Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling pathway in human colon cancer cells. Cancer Res., 60: 6886-6889, 2000.
20. 2 arrest after DNA damage. Science (Wash. DC), 282: 1497-1501, 1998.
21. Artandi, S. E., Alson, S., Tietze, M. K., Sharpless, N. E., Ye, S., Greenberg, R. A., Castrillon, D. H., Homer, J. W., Weiler, S. R., Carrasco, R. D., and DePinho, R. A. Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc. Natl. Acad. Sci. USA, 99: 8191-8196, 2002.
22. Gonzalez-Suarez, E., Samper, E., Ramirez, A., Flores, J. M., Martin-Caballero, J., Jorcano, J. L., and Blasco, M. A. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J., 20: 2619-2630, 2001.
23. Farwell, D. G., Shera, K. A., Koop, J. I., Bonnet, G. A., Matthews, C. P., Reuther, G. W., Coltrera, M. D., McDougall, J. K., and Klingelhutz, A. J. Genetic and epigenetic changes in human epithetial cells immortalized by telomerase. Am. J. Pathol., 156: 1537-1547, 2000.
24. Xiang, H., Wang, J., Mao, Y., Liu, M., Reddy, V. N., and Li, D. W. Human telomerase accelerates growth of lens epithelial cells through regulation of the genes mediating RB/E2F pathway. Oncogene, 21: 3784-3791, 2002.